Results 181 to 190 of about 69,627 (265)

Relapsing allergic bronchopulmonary aspergillosis as a trigger for Kounis syndrome: a case report. [PDF]

Front Cardiovasc Med
Wei H, Wu L, Ni B, Zhang J, Xu M, Guo L, Mao Y.   +6 more
europepmc   +1 more source

Effect of sodium–glucose cotransporter 2 inhibitors on heart failure readmission in older patients with diabetes: A Japanese claims‐based cohort study

Journal of Diabetes Investigation, EarlyView.
SGLT2 inhibitor use at discharge was associated with a reduced risk of heart failure readmission in elderly patients with diabetes, with no significant differences among individual agents. ABSTRACT Aims To evaluate the effect of sodium–glucose cotransporter 2 inhibitor (SGLT2i) administration at hospital discharge on heart failure (HF) readmission ...
Kazuya Hiura, Hirotaka Masuda, Masayuki Sakunami, Miki Yamashita   +3 more
wiley   +1 more source

Biobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy. [PDF]

Circ Genom Precis Med
Chan JH, Grace C, Mazidi M, Clarke R, Ho CY, Neubauer S, Kramer CM, Watkins H, Goel A, HCMR Investigators.   +9 more
europepmc   +1 more source

Dapagliflozin does not impair microvascular hemorheology in type 2 diabetes mellitus: A multicenter randomized controlled trial (D‐PATH study)

Journal of Diabetes Investigation, EarlyView.
Graphical abstract illustrating the study design, physiological rationale, and key findings of the D‐PATH trial. Dapagliflozin, an SGLT2 inhibitor, lowers HbA1c and body weight while increasing hematocrit and erythropoietin levels. Although an elevated hematocrit could theoretically increase blood viscosity and impair microcirculatory flow, ex vivo ...
Yuki Nakatani, Nobuyuki Banba, Shoya Ono, Tomoki Turumi, Megumi Hoshiai, Takushi Sugiyama, Takashi Tomoe, Hajime Tamiya, Naoyuki Otani, Hiroyuki Sugimura, Hidekazu Ikemiyagi, Yusuke Ohya, Koji Yokokawa, Shinichiro Ueda, Yoshimasa Aso, Yasuhiro Maejima, Takanori Yasu   +16 more
wiley   +1 more source

Screening for HFpEF in pacemaker patients: Study design and protocol of the PM-HFpEF study. [PDF]

PLoS One
Santos E, Teixeira R, Almeida J, Fonseca P, Oliveira M, Gonçalves H, Primo J, Diaz S, Barros A, Vilela E, Sampaio F, Saraiva F, Oliveira M, de Carvalho RF.   +13 more
europepmc   +1 more source

The prevalence of frailty and associated factors in patients with type 2 diabetes mellitus and coronary heart disease: A cross‐sectional study

Journal of Diabetes Investigation, EarlyView.
Among 217 participants, 43.8% were frail. Frailty was common among patients with T2DM and CHD. Blood glucose, BNP, anxiety, sleep duration, nutritional risk, history of PCI, and age were independently associated with frailty in patients with T2DM and CHD.
Junwen Ma, Jing Wang, Wei Zhu
wiley   +1 more source

Postpartum cardiac complications after hypertensive disorders of pregnancy: predictive roles of retinal arteriolar-to-venular ratio and NT-proBNP. [PDF]

Am J Transl Res
Ju G, Zhuang Y, Liao Z, Tang D.
europepmc   +1 more source

Amiodarone‐related thyroid dysfunction and associated outcomes in patients with heart failure—A nationwide cohort study

Journal of Internal Medicine, EarlyView.
Abstract Aim Amiodarone increases the risk of thyroid dysfunction, but the prognostic significance of this complication in patients with heart failure (HF) is uncertain. This study investigates the association between amiodarone‐related thyroid dysfunction and risk of HF hospitalization or death in a nationwide cohort.
Søren Lund Kristensen, Sam Aiyad Ali, Mads Ersbøll, Jawad Haider Butt, Rasmus Rørth, Lucas Malta Westergaard, Lauge Østergaard, Finn Gustafsson, Oren Caspi, Emil Fosbøl, Lars Køber, Christian Selmer   +11 more
wiley   +1 more source

Trametinib Therapy for Hypertrophic Cardiomyopathy and Pulmonary Hypertension in a Child With RAF1-Related Noonan Syndrome (p.Ser257Leu): A Case Report. [PDF]

Clin Case Rep
Nilsson CN, Aljohani OA, Smith MA, Durand R, Sheyanth IN, Nawaytou H, Stieglitz E, Valle R, Datar SA.   +8 more
europepmc   +1 more source

Prevalence, Comparative Risk, and Predictors of Shock in Children With Multisystem Inflammatory Syndrome Associated With COVID‐19: A Systematic Review and Meta‐Analysis

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Background Multisystem inflammatory syndrome in children (MIS‐C) is a severe hyperinflammatory condition associated with SARS‐CoV‐2 infection and is frequently complicated by cardiovascular dysfunction, particularly shock. Early recognition of shock in MIS‐C is critical to reduce morbidity and mortality.
Asif Jan, Bushra Waheed, Ghadah Ali Hussein, Pratima Pandey, Huma Sultana, Shubham Kumar, Mequanente Dagnaw   +6 more
wiley   +1 more source